| Dr Leon M Tolman, MD | |
|
600 Medical Arts Bldg Ste 610, Kittanning, PA 16201-7134 | |
| (724) 545-6625 | |
| (724) 545-6627 |
| Full Name | Dr Leon M Tolman |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 600 Medical Arts Bldg Ste 610, Kittanning, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811918022 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD025366E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leon M Tolman, MD 600 Medical Arts Bldg Ste 610, Kittanning, PA 16201-7134 Ph: (724) 545-6625 | Dr Leon M Tolman, MD 600 Medical Arts Bldg Ste 610, Kittanning, PA 16201-7134 Ph: (724) 545-6625 |
News Archive
The American Association of Physicists in Medicine (AAPM) has issued a statement today in the wake of several recent articles in the New York Times yesterday and earlier in the week that discuss a number of rare but tragic events in the last decade involving people undergoing radiation therapy.
ChemoCentryx, Inc., today announced that it reported positive preclinical and Phase I study results at the European Association for the Study of Diabetes (EASD). CCX140, a novel, orally bioavailable small molecule antagonist of the chemokine receptor CCR2, improved metabolic function while significantly reducing inflammatory macrophages found in adipose tissue in an animal model, and was well tolerated in Phase I clinical trials.
YM BioSciences Inc., today provided an update on the development program for nimotuzumab, including its North American clinical program for nimotuzumab, manufacturing scale-up activities, and data presentations anticipated for nimotuzumab at the 2011 Annual Meeting of the American Society of Clinical Oncology.
Sinovac Biotech Ltd., a leading developer and provider of vaccines in China, announced today that its wholly-owned subsidiary, Sinovac Biotech (Hong Kong) Ltd, has received the Certificate of Approval to distribute Panflu(TM) (H5N1), its H5N1 (bird flu) pandemic influenza vaccine, in Hong Kong. The certificate is valid through September 13, 2014 and thereafter will be renewable for periods of five years at a time, subject to payment of the registration fee.
› Verified 2 days ago
Dr. Diego R Cordoba, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Medical Arts Bldg, Suite 140, Kittanning, PA 16201 Phone: 724-548-4701 Fax: 724-548-2003 | |
Charles R Betts, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Nolte Dr, Suite 150, Kittanning, PA 16201 Phone: 724-548-1395 Fax: 412-548-1396 | |
Dr. Larry B Wingard, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Medical Arts Bldg, Suite 150, Kittanning, PA 16201 Phone: 724-543-5919 Fax: 724-543-3544 | |
Rakhshinda Parvin Zafar, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 117 Country Club Ln, Kittanning, PA 16201 Phone: 734-525-5981 | |
Dr. Jon R Belasco, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Nolte Dr Bldg 100, Suite 150, Kittanning, PA 16201 Phone: 724-543-5919 Fax: 724-543-3544 | |
Dr. Julia Zefirova, M.D., PHD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Nolte Dr, Kittanning, PA 16201 Phone: 724-906-4832 | |
Jyothika Mamadgi, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Nolte Dr, Kittanning, PA 16201 Phone: 724-543-8657 |